Category: Health & Medicines > Medicines > Adefovir Dipivoxil
Country/Region: China State/Province: Beijing
Main Products: ENTECAVIR, ADEFOVIR, TENOFOVIR, PACLITAXEL, DOCETAXEL
Business Type: Supplier, Trader
Year Established: 2003
Employees: Above 1000 People
Plant Area: 10,000-30,000 square meters
Main Markets: South America 11% Africa 9% Eastern Asia 10% Domestic Market 10% North America 10% Eastern Europe 12% Southern Europe 10% Mid East 8% Northern Europe 10% Oceania 10%
Trade Capacity: FOB, CIP, DDP
Contract Manufacturing: OEM Service Offered Design Service Offered
Nearest Port: Beijing
Annual Revenue: US$1 Million - US$2.5 Million
Total Revenue: US$5 Million - US$10 Million
Export Revenue: US$50 Million - US$100 Million
Annual Output: US$50 Million - US$100 Million
Registered Capital: US$50 Million - US$100 Million
Export Percentage: 81% - 90%
Payment Modes: USD, AUD, GBP
Lead Time: 18 days
Import/Export Mode: LLC (Limited Liability Corp)